Profil
Antonio Herce is an Investment Director at Inveready Asset Management SGEIC SA. He is also a Board Member at Bionanoplus SL, Atlas Molecular Pharma SL, and 3D-Shaper Medical.
Mr. Herce completed his undergraduate degree at the University of Lleida in 2015 and his graduate degree at the University of Barcelona in 2016.
Postes actifs de Antonio Herce
| Sociétés | Poste | Début |
|---|---|---|
Inveready Asset Management SGEIC SA
Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready invests in both public and private companies located in Europe and North America. The firm targets companies operating in the fields of infrastructure, life sciences and technology sectors. It provides debt and equity financing for buyouts, secondary, early and growth capital requirements with an investment size ranging between EUR 0.5 million and 5 million. | Private Equity Investor | 01/05/2023 |
Atlas Molecular Pharma SL
Atlas Molecular Pharma SL Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of therapeutics for the treatment of patients suffering from rare diseases | Directeur/Membre du Conseil | 01/01/2022 |
3D-Shaper Medical | Directeur/Membre du Conseil | 01/03/2021 |
Bionanoplus SL
Bionanoplus SL BiotechnologyHealth Technology Designs and develops drug delivery systems | Directeur/Membre du Conseil | 01/12/2019 |
Formation de Antonio Herce
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Barcelona
University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inveready Asset Management SGEIC SA
Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready invests in both public and private companies located in Europe and North America. The firm targets companies operating in the fields of infrastructure, life sciences and technology sectors. It provides debt and equity financing for buyouts, secondary, early and growth capital requirements with an investment size ranging between EUR 0.5 million and 5 million. | Finance |
University of Lleida
University of Lleida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bionanoplus SL
Bionanoplus SL BiotechnologyHealth Technology Designs and develops drug delivery systems | Health Technology |
Atlas Molecular Pharma SL
Atlas Molecular Pharma SL Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of therapeutics for the treatment of patients suffering from rare diseases | Commercial Services |
3D-Shaper Medical |
















